Evidence map›Paper›PMID 34941670›Full record

ReviewToxins2021

Miryam Paola Alvarez-Flores, Renata Nascimento Gomes, Dilza Trevisan-Silva, Douglas Souza Oliveira, Isabel de Fátima Correia Batista, Marcus Vinicius Buri, Angela Maria Alvarez, Carlos DeOcesano-Pereira, Marcelo Medina de Souza, Ana Marisa Chudzinski-Tavassi

Abstract readReview
In one paragraph

Review in Toxins, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Venom-Derived Proteins fromInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Toxins · 2023
    Article
  5. Article
  6. Article
  7. Losac and Lopap Recombinant Proteins fromFrontiers in molecular biosciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miryam Paola Alvarez-FloresCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.ORCID 0000-0002-7986-923X
Renata Nascimento GomesCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.
Dilza Trevisan-SilvaCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.
Douglas Souza OliveiraCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.ORCID 0000-0001-8919-4996
Isabel de Fátima Correia BatistaCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.ORCID 0000-0001-7398-4184
Marcus Vinicius BuriCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.
Angela Maria AlvarezCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.ORCID 0000-0002-9056-9764
Carlos DeOcesano-PereiraCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.ORCID 0000-0002-8933-4474
Marcelo Medina de SouzaCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.
Ana Marisa Chudzinski-TavassiCentre of Excellence in New Target Discovery (CENTD), Butantan Institute, Butantã 05503-900, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a tribute to Butantan Institute in its 120th anniversary, this review describes some of the scientific research efforts carried out in the study of

Indexed as

AnimalsArthropod VenomsBrazilButterfliesHumansInsect Bites and StingsLarvaArthropod VenomsenvenominginnovationLonomia

Identifiers

PMID34941670
PMCPMC8706654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.